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Only one study has reported on the medicinal properties of Cordia platythyrsa (C. platythyrsa) though it 
is used in African traditional medicine for treatment of fever and pain. The current study aimed at 
investigating the analgesic and anti-inflammatory properties of C. platythyrsa using various animal 
models: writhing test, tail flick, thermal hyperalgesia, mechanically induced-pain, formalin-induced pain 
and carrageenan-induced inflammation tests. Like aspirin, the two doses of plant extracts used 
inhibited acetic acid-induced pain though these effects were weaker than the effects of morphine. 
Although, the plant extract significantly (p<0.01) inhibited thermal pain, its effects were less significant 
compared to morphine. Celecoxib (10 mg/kg) and plant extract (100 mg/kg) significantly inhibited 
thermal hyperalgesia compared to indomethacin. On the other hand, both doses of plant extract 
significantly increased mechanical pain thresholds 30 and 90 min post treatment. The plant extract (150 
mg/kg) inhibited both the neurogenic and inflammatory pain phases of formalin-induced pain as well as 
carrageenan-induced inflammation. This study is the first to show that C. platythyrsa has analgesic and 
anti-inflammatory properties. 
 





Cordia platythyrsa (Baker) is a boragenaceae which 
grows up to 30 m high and about 3 m in girth. It is com-
monly found in secondary forests stretching from Sierra 
Leone to Congo. Its wood is used for furniture and 
building. In fishing communities, it is the wood of choice 
for canoe manufacturing due to its fungal and insect 
resistant properties (Burkil, 2004). In Cameroon, the 
young leaves of this plant are used for the treatment of 
cough and tuberculosis (Simbo, 2010). Some plants from 
the Cordia genus have been shown to have anti-inflam-
matory, antimicrobial and anti-snake venom activities 
(Sertie, 2005; Kloucek, 2007; Ticli, 2008). Recently, a 
new dioxime (cordioxime) with gamma-lactam activity 
was isolated and characterized from extracts of C. 
platythyrsa (Christelle et al., 2011).  
Besides the aforementioned study, no other study has 
been reported on the medicinal properties of C. 
platythyrsa. The purpose of this study was therefore to 
investigate the anti-inflammatory and analgesic proper-
ties of the methanol extract of C. platythyrsa using
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various animal models of pain. 
 
 




Stem barks and plant samples of C. platythyrsa were collected 
around Yaoundé and authenticated in the National Herbarium in 
Yaoundé - Cameroon where a voucher specimen was deposited 
(YA0032566). Tree barks were air dried and then extracted in 
methanol for 72 h after which the solvent was recovered from the 
extract using a rotary evaporator. The obtained paste extract was 





Wistar rats (150 to 200 g) and Swiss mice (20 to 30 g) of either sex 
were obtained from the South African Vaccine Producers (SAVP). 
Animal were housed in our animal holding facility and allowed a one 
week period for acclimatization during which they had free access 
to both food and water. Prior to treatment, experimental animals 
were fasted overnight but allowed access to drinking water. Ethical 
approval for this study was obtained from the Walter Sisulu 





Morphine, aspirin and celecoxib were supplied by Pfizer 
Pharmaceuticals while indomethacin and carrageenan were 




Acetic acid-induced writhing response in mice 
 
Five groups of five mice each were randomly selected for the 
present study. Group one received 0.09% NaCl (control group) 
while groups two and three received aspirin (100 mg/kg) and 
morphine (10 mg/kg), respectively. The last 2 groups received 100 
and 150 mg/kg of C. Platythyrsa extract. 30 min after treatment with 
drugs, each rat received a 0.5 ml ip injection of 1% v/v acetic acid 
solution. Injected animals were placed individually in transparent 
cages and the number of abdominal contortions followed by 
stretching of the limbs (writhes) was counted for each animal for a 
period of 30 min. A reduction in the number of writhes induced by 
drug treatments compared to response in control animals was 
considered as a positive analgesic response. The percentage 
inhibition of writhing was then calculated using the following 
formula: 
 
[1-(T/C)] × 100 
 
Where, T is the number of writings of the treated group and C is the 





A separate group of mice were randomly allocated to one of five 
groups which received treatment as described earlier. Rats were 
lightly restrained and posterior third of tail allowed to lie over a glass 
window slit of the Tail Flick meter (Ugo Basile, model: 37450-001) 
as previously described by Nkeh-Chungag et al. (2010). Baseline 
latencies for tail withdrawal from radiant light source were 










Five groups of wistar rats were randomly assigned to different 
treatment groups in the present study. The first group received 
0.09% NaCl while groups 2 and 3 were pre-treated with aspirin (100 
mg/kg) and morphine 10 mg/kg, respectively. Groups 4 and 5 were 
pre-treated with 100 and 150 mg/kg of methanol extract of C. 
Platythyrsa. Pre-treatment was followed 30 min later by a 50 µl sub-
plantar injection of 0.5% carrageenan solution. Paw withdrawal 
latency to a thermal stimulus was measured using Tail Flick 
analgesia meter (Ugo Basile, model: 37450-001) at various time 
intervals after carrageenan injection. Paw withdrawal latency before 
carrageenan injection - Paw withdrawal latency at any given times 





Briefly, rats were kept in Perspex boxes with a metallic grid floor 
through which the filament was pressed unto the plantar surfaces of 
rat hind-paws with just enough force to bend filaments for 
approximately 1 s. The force applied and the withdrawal latency 
were determined 5 times for each rat - this constituted the baseline 
data. After determining the baseline, the animals were then 
randomly assigned to one of five treatment groups. Animals were 
then treated with: 0.09% NaCl, aspirin (100 mg/kg), morphine 10 
mg/kg, 100 or 150 mg/kg of methanol extract of C. Platythyrsa. 
Mechanical pain thresholds were again determined at different time 





The formalin test was carried out as described by Prabhu et al. 
(2011) with some modifications.  Five groups of mice were selected 
for the present study. Group one received 0.09% NaCl (control 
group) and group two and three received celecoxib (10 mg/kg) and 
indomethacin (20 mg/kg), respectively. The last two groups (groups 
4 and 5) received 100 and 150 mg/kg of the methanol extract of C. 
Platythyrsa respectively. One hour (1 h) after treatment with the 
various drugs, animals were injected sub-plantarly with a 100 µl of 
1% formalin solution. Animals responded to formalin injection by 
licking or biting the injected paw. The number of times the animal 
licked/bit the paw was recorded during the first 5 min (neurogenic 
phase) and then 20 to 30 min (inflammatory phase) after formalin 
injection. The percentage inhibition was then calculated using the 
following formula: 
 
[1-(T/C)] × 100 
 
Where, T is the number of times treated mice licked/bit the injected 




Carrageenan-induced paw inflammation 
 
Rats were randomly allocated to one of four groups and baseline 
paw volumes determined using an Ugo Basile plethysmometer 
(Model 7140) which determines paw volume by fluid displacement 
techniques. 30 min after pre-treatment with 0.09% NaCl, celecoxib 
10 mg/kg), 100 or 150 mg/kg methanol extract of C. Platythyrsa, 
100µl of 1% carrageenan in saline was injected into the right hind 
paw of rats. Paw volumes were again determined at various 
intervals after carrageenan injection. Change in paw volume was 
determined  
 




Table 1. Analgesic effect of oral treatment with C. Platythyrsa on acetic 
acid-induced writhing in mice. 
 
Treatment Dose (mg/kg) Writhes/30 min Inhibition (%) 
Control  76 ± 2 - 
C. Platythyrsa 100 58 ± 4* 24 
C. Platythyrsa 150 55 ± 10* 27 
Morphine 10 14 ± 1*** 82 
Aspirin 100 44 ± 2** 43 
 




Table 2. Antinociceptive effect of oral treatment with C. Platythyrsa on thermal pain. 
 
Treatment Dose (mg/kg) 
Latency (s) 
0 min 30 min 60 min 90 min 
Control  3.8 ± 0.3 4.6 ± 0.3 4.9 ± 0.4 5.1 ± 0.4 
C. Platythyrsa 100 4.4 ± 0.7 7.9 ± 0.5** 4.9 ± 0.4 4.8 ± 0.3 
C. Platythyrsa 150 4.7 ± 0.7 8.4 ± 0.4** 5.2 ± 0.3 5.3 ± 0.6 
Morphine 10 4.4 ± 0.4 6.4 ± 0.5* 7.2 ± 0.6* 5.5 ± 0.5 
Aspirin 100 4.3 ± 0.4 4.7 ± 0.4 4.5 ± 0.5 5.5 ± 0.6 
 




by subtracting paw volume at baseline from paw volume at 







was used to perform ANOVA followed by 
Dunnet’s test. Results from each treatment group were compared 
with results obtained from the control group at specified times. 






Acetic acid-induced writhing response in mice 
 
Intraperitoneal injection of 1% v/v acetic induced 
abdominal contortions and stretching of hind limbs. 
Extracts of C. platythyrsa significantly reduced writhing 
responses in a dose dependent manner. On the other 
hand, aspirin reduced the number of abdominal writhes 
better than either doses of the plant extract. However, the 
analgesic effect of aspirin was weaker than the effect of 
morphine which was significantly better than the effect of 
aspirin and C. platythyrsa, respectively (Table 1). 
Whereas, morphine inhibited acetic acid induced pain by 
82% and aspirin by 43%, both plant extracts inhibited this 





Paw withdrawal latencies  were significantly increased  in 
the extract treated groups 30 min after drug 
administration (Table 2). Morphine on the other hand 
significantly increased paw withdrawal latencies during 
the 30 and 60 min periods. Aspirin however, did not 






The difference in pain thresholds between carrageenan-
injected and saline-injected paws increased in a time 
dependent manner in untreated animals. The lower dose 
of plant extract and celecoxib however, showed the 
smallest differences in paw withdrawal latencies between 
saline-injected and carrageenan-injected paws 120 and 
180 min after oral treatment with drugs. Indomethacin on 
the other hand had very little effect on this pain model as 
indicated by the non-significant differences in paw 
withdrawal latencies of saline- and carrageenan-injected 





Response to mechanical pain as tested with Von Frey 
filaments improved with treatment. Pain thresholds were 
significantly increased in all treatment groups compared 
to the control group. C. platythyrsa (100 mg/kg) showed 
slightly greater analgesic effects throughout the 
experimental period. Morphine and aspirin significantly 
and consistently reduce mechanical pain response with 
 




Table 3. Effect of oral treatment with C. platythyrsa on thermal hyperalgesia. 
 
Treatment Dose mg/kg 15 min 60 min 120 min 180 min 
Control  2.1 ± 0.3 1.8 ± 0.1 2.8 ± 0.3 3.1 ± 0.2 
C. Platythyrsa 100 1.1 ± 0.2 1.2 ± 0.1 0.7 ± 0.3* 0.7 ± 0.3** 
C. Platythyrsa 150 1.4 ± 0.4 1.5 ± 0.4 1.4 ± 0.2 1.4 ± 0.2 
Celecoxib  10 1.4 ± 0.4 0.5 ± 0.4 1.3 ± 0.2* 0.8 ± 0.5* 
Indomethacin 20 1.3 ± 0.3 1.7 ± 0.2 2.0 ± 0.2 1.6 ± 0.2 
 




Table 4. Antinociceptive effect of oral treatment with C. Platythyrsa on mechanically-induced 
pain. 
 
Treatment Dose (mg/kg) 
Force applied (g/f) 
0 min 30 min 60 min 90 min 
Control  11.5 ± 1.1 14.7 ± 1.4 15.5 ±  1.3 13.4 ± 1.1 
C. Platythyrsa 100 16.1 ± 1.1 19.4 ± 1.5* 21.3 ± 0.9* 21.7 ± 1.3** 
C. Platythyrsa  150 14.7 ± 1.1 18.4 ± 1.5 20.4 ± 1.4* 18.1 ± 1.1* 
Morphine  10 11.5 ± 1.1 25.3 ± 1.8** 20.9 ± 1.5* 26.8 ± 2.1** 
Aspirin 100 20.9 ± 1.5 29.9 ± 1.6** 33.6 ± 1.2** 21.9 ± 1.1** 
 




Table 5. Antinociceptive effect of oral treatment with C. Platythyrsa on formalin-induced pain. 
 
Treatment Dose (mg/kg) 
Neurogenic pain (0 to 5’)  Inflammatory pain (20 to 30’) 
Number of licks/bite Inhibition (%)  Number of licks/bites Inhibition (%) 
Control  129 ± 2 -  137 ± 2 - 
C. Platythyrsa 100 71 ± 5* 36  54 ± 8* 45 
C. Platythyrsa 150 79 ± 3* 39  52 ± 6** 62 
Morphine 10 35 ± 4** 63  25 ± 8** 82 
Aspirin 100 72 ± 6* 47  65 ± 1* 53 
 




aspirin activity peaking at 30 and 60 min post treatment 
while the effects of morphine continued to increase 





Typically, formalin-induced pain occurs in two phases: 
the first (neurogenic) phase during the first 5 min after 
formalin injection followed by a period of relative calm 
and then a second (inflammatory) phase of pain between 
20 and 30 min after formalin injection. All drugs had an 
effect on both the neurogenic and inflammatory phases of 
the formalin-induced pain (Table 5). Morphine treated 
animals had the lowest number of licks/bites in response 
to formalin injection - an effect which was better in the 
inflammatory phase of the response. Aspirin did not show 
any difference in response between the two response 
phases. The plant extracts however showed better 
analgesic properties in the inflammatory phase compared 
to the neurogenic phase. 
 
 
Carrageenan-induced inflammation test 
 
Carrageenan induced a steady and time dependent 
increase in injected paw volume in control animals. Pre-
treatment with 100 and 150 mg/kg of the extract 
significantly inhibited inflammation from the second hour 
after oral dosing though the effect of the former became 
non-significant at the 5th h post treatment. The anti-
inflammatory effects of celecoxib were significant from 
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the 3rd h after drug administration and improved further 
during the 5th h (Figure 1). Although, the anti-inflam-
matory effect of 100 mg/kg was better than that of the 
150 mg/kg during the first 2 h after drug administration, 
these effects became weaker beyond the 4th h while the 
effects of the latter became better and significant beyond 





In the present study, we investigated the analgesic and 
anti-inflammatory properties of methanol extract of C. 
platythyrsa tree bark. This study showed that the extract 
has both analgesic and anti-inflammatory properties as 
reported for other Cordia spp. We used five different 
models of pain to evaluate the analgesic properties of this 
extract: the acetic acid-induced writhing test, tail flick test, 
thermal hyperalgesia, von Frey mechanical pain model 
and formalin-induced pain test as well as the 
carrageenan-induced inflammatory model to show that 
the methanol extract of C. platythyrsa has both analgesic 
and anti-inflammatory properties. The writhing test also 
called acetic acid-induced abdominal writhing which is a 
visceral pain model is used generally for screening 
compounds for analgesic properties. This test is a non 
specific model of evaluating analgesia used to elucidate 
peripheral activity of tested compounds (Sánchez-Mateo 
et al., 2006). The nociceptive mechanism of this test 
involves prostaglandin biosynthesis via cyclooxygenase 
from arachidonic acid (Ikeda et al., 2001; Franzotti et al., 
2002). Results of the present study showed that both 
doses of C. platythyrsa used produced significant 
analgesic effect which might be due to inhibition of the 
cyclooxygenase or arachidonic acid metabolite. Previous 
reports however, show that the acetic acid-induced 
abdominal writhing test is a nonspecific test which 
responds to both central and peripheral analgesics (Le 
Bar et al., 2001; Malec et al., 2008). Therefore, because 
of the lack of specificity of this model, other more specific 
mechanisms were investigated. 
The tail flick test which is based on the withdrawal 
latency to a thermal stimulus is sensitive to central agents 
such as opioid analgesics (Chakraborty et al., 2004) but 
not NSAIDs. In this study however, morphine failed to 
protect against this model of pain while the extract 
showed some activity. Thermal stimulus in this test is 
transmitted from the periphery to the spinal cord via C 
fibres. The methanol extract of C. platythyrsa may 
therefore inhibit transmission of pain to the spinal cord by 
inhibition of nerve impulses in the C-fibres. To further 
clarify these findings, the mechanical pain model using 
von Frey filaments was used. This test is used to 
differentiate between drugs with a central opioid-like 
action mechanism from peripheral analgesics. Morphine, 
a central acting agent, inhibited this pain model from 1 to 
5 h and beyond. Like morphine, the two doses of plant 
extract also inhibited mechanical pain  thus  confirming its 
 




central acting analgesic activity. The formalin test 
provides a model of behavioural pain response which 
closely resembles clinical pain (Doak and Sawynok, 
1997; Roveroni et al., 2001). In this test, animals 
presented two distinct nociceptive behavioural phases, 
which involve different stimuli. 
The first phase also referred to as neurogenic phase 
begins immediately after formalin injection and lasts for 
up to 5 min, is said to be caused by the direct stimulation 
of nociceptors (Abdollahi et al., 2002). The second phase 
also known as the inflammatory phase which lasts from 
20 to 30 min after formalin injection results from the 
release of mediators of inflammation into peripheral 
tissue. Pain in this second phase is due to tissue damage 
and consequently sensitive to the actions of NSAIDs 
(Hwang et al., 2008). Opioid analgesics however, are 
capable of inhibiting the early and late phases of the 
formalin-induced pain (Vasudevan et al., 2007). In this 
study, C. Platythyrsa significantly inhibited both phases of 
the formalin test suggested that this extract may have an 
endogenous opioid-like analgesic activity on µ-opioid 
receptors which are tonically activated by formalin 
injection (Zhao et al., 2003) as well as anti-inflammatory 
properties. Carrageenan-induced inflammation occurs in 
two phases: the early phase which occurs between 1 to 2 
h after injection of the phlogistic agent is mediated by the 
release of histamine, serotonin and bradykinin; while the 
late phase which may last for up to 6 h after carrageenan 
injection involves the active release of TNF-alpha, IL 
1beta, COX-2 and prostaglandins which tend to worsen 
the inflammatory reaction (Gupta et al., 2006; Loram et 
al., 2007). The two doses of C. platythyrsa extract inhi-
bited both phases of carrageenan-induced inflammation 
while celecoxib and other NSAIDs inhibit the second 
phase of this inflammatory process via cyclooxygenase 
inhibition. 
The inhibitory activity shown by both extract doses in 
the first and second phases may indicate an ability of the 
extract to inhibit histamine and serotonin release as well 
as inhibit the activity of cyclooxygenase which mediates 





Based on the results of this study, it can be concluded 
that C. Platythyrsa possesses both analgesic and anti-
inflammatory properties thus justifying its ethnomedicinal 
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